Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease

Introduction of isopropyl group at third position of imidazo[1,5-a]pyridine dramatically changed the activity from antagonist to agonist towards 5-HT4 receptor.